Brief: SOBI Updates Guidance For 2026

Swedish Orphan Biovitrum AB (publ)

16/07/2026 07:08

July 16 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
SOBI Q2 REVENUE SEK 7,842 MILLION VERSUS. IBES ESTIMATE SEK 7,289 MILLION
SOBI Q2 EBIT SEK 1,627 MILLION VERSUS. IBES ESTIMATE SEK 1,795 MILLION
SOBI Q2 ADJUSTED FREE CASH FLOW SEK 1,912 MILLION
SOBI Q2 ADJUSTED EPS SEK 3.17
OUTLOOK 2026 - UPDATED 
REVENUE IS ANTICIPATED TO GROW BY A MID-TO HIGH-TEENS PERCENTAGE AT CER (PREVIOUSLY LOW DOUBLE-DIGIT)
OUTLOOK 2026 - UPDATED ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE IN MID-TO HIGH-30S PERCENTAGE OF REVENUE (PREVIOUSLY MID 30S)
SEES 2026 REVENUE TO GROW BY A MID-TO HIGH-TEENS PERCENTAGE AT CER (PREVIOUSLY LOW DOUBLE-DIGIT)
SEES 2026 ADJUSTED EBITA MARGIN TO BE IN MID-TO HIGH-30S PERCENTAGE OF REVENUE (PREVIOUSLY MID 30S)
Source text: ID:nWkr7SKy15
Further company coverage: SOBIV.ST

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))